Baldiness

Intercytex Inks 10 Year Deal with BioLife Solutions

by Bald Man on May 7th, 2007

From the press release:

BioLife Solutions Inc. , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells and tissues, today announced a supply and licensing agreement with Intercytex Group plc, a Cambridge, UK, and Boston-based cell therapy company.

The agreement lasts 10 years and covers permits Intercytex access to the HypoThermosol storage and preservation media for both VAVELTA (ICX-RHY), the facial rejuvenation product, which is expected to hit the market soon, as well as ICX-TRC, the hair regeneration product still under development.

Intercytex Chief Executive Nick Higgins said:

“We completed a thorough evaluation of several commercial and generic hypothermic storage and preservation media products. HypoThermosol clearly outperformed all competing alternatives, so securing long-term access to the product was a priority.”

Share This

Related Stories

Neosil Secures $10M in Funding
Intercytex Still in the Red
Possible Dirt Behind Intercytex Grant
Intercytex Reviewed by UK Motley Fool
Intercytex Raising £12 Million Via Stock

POSTED IN: Bald Business, Bald Medicine